Nexavar
Payments companies reported to CMS as associated with Nexavar. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nexavar, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nexavar
These are the largest totals companies reported as associated with Nexavar. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Kim | Tampa, FL | Hematology & Oncology | $3,060.21 |
| John Strickler | Durham, NC | Medical Oncology | $2,457.00 |
| John Marshall | Washington, DC | Hematology & Oncology | $1,750.00 |
| Madappa Kundranda | Gilbert, AZ | $1,425.00 | |
| Kirsten Blue | Tampa, FL | Physician Assistant | $226.31 |
| Chandler Kracht | Tampa, FL | Physician Assistant | $226.31 |
| Mehmet Akce | Birmingham, AL | Hematology & Oncology | $210.30 |
| Darryl Outlaw | Birmingham, AL | Hematology & Oncology | $210.30 |
| Jeremy Jones | Jacksonville, FL | Hematology & Oncology | $201.28 |
| Ashton Boyle | Duval, FL | Physician Assistant | $193.69 |
Prescribed Nexavar?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.